Safety and preliminary activity of pembrolizumab-carboplatin-paclitaxel in heavily pretreated and/or fragile patients with PDL1-positive recurrent/metastatic head and neck cancer

1. Cabezas-Camarero, S.
2. Merino-Menéndez, S.
3. Cabrera-Martín, M.N.
4. Sotelo, M.J.
5. Plaza-Hernández, J.C.
6. Falahat, F.
7. Iglesias-Moreno, M.C.
8. Pérez-Segura, P.